| Literature DB >> 33603971 |
Joseph A Ippolito1,2, Haichan Niu1, Nicole Bertoletti2, Zachary J Carter1, Shengyan Jin2, Krasimir A Spasov2, José A Cisneros1, Margarita Valhondo1, Kara J Cutrona1, Karen S Anderson2,3, William L Jorgensen1.
Abstract
Covalent inhibitors of wild-type HIV-1 reverse transcriptase (CRTIs) are reported. Three compounds derived from catechol diether non-nucleoside inhibitors (NNRTIs) with addition of a fluorosulfate warhead are demonstrated to covalently modify Tyr181 of HIV-RT. X-ray crystal structures for complexes of the CRTIs with the enzyme are provided, which fully demonstrate the covalent attachment, and confirmation is provided by appropriate mass shifts in ESI-TOF mass spectra. The three CRTIs and six noncovalent analogues are found to be potent inhibitors with both IC50 values for in vitro inhibition of WT RT and EC50 values for cytopathic protection of HIV-1-infected human T-cells in the 5-320 nM range.Entities:
Year: 2021 PMID: 33603971 PMCID: PMC7883463 DOI: 10.1021/acsmedchemlett.0c00612
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345